Guideline Summary: Management of Functional Puborectalis Dysfunction and Dyssynergic Defecation

Evidence Regarding Structural Injury

No documented cases in the medical literature show a puborectalis muscle rupture resulting from a single episode of forceful straining during constipation. This absence of evidence supports the conclusion that such injuries are exceedingly rare. 1

Patients with suspected dyssynergic defecation should be referred to a gastroenterology or pelvic‑floor specialist for anorectal manometry, balloon‑expulsion testing, and biofeedback therapy to confirm functional outlet obstruction and exclude structural damage. 1

Biofeedback therapy is the definitive first‑line treatment for dyssynergic defecation, carrying Grade A evidence and achieving 70–80 % success rates by retraining the pelvic floor to relax during evacuation. 1
Biofeedback is superior to laxative therapy for defecatory disorders because it addresses the underlying learned dyssynergia rather than merely masking symptoms. 1

Discontinue all constipating medications (e.g., opioids, anticholinergics, calcium‑channel blockers) when feasible to reduce functional outlet obstruction. 1
Initiate polyethylene glycol (approximately 17 g daily) as an osmotic laxative to soften stools and lower intrarectal pressure during defecation. 1

Surgical procedures such as sphincterotomy or muscle repair should not be performed without first confirming the diagnosis with anorectal manometry and attempting biofeedback, because surgery on unrecognized dyssynergic patterns can lead to disastrous outcomes. 1

Early referral to a pelvic‑floor specialist—ideally within 3–6 months of symptom onset—yields better long‑term results than prolonged conservative management alone. 1

All statements are derived from the cited Gastroenterology 2013 guideline (1).

Stimulant laxatives, such as senna and bisacodyl, do not damage intestinal neurons or muscle, according to the European Society of Gastrointestinal Motility 2
Chronic laxative use is safe for long-term management of normal transit and slow transit constipation, as stated by the American Gastroenterological Association 3
The American Gastroenterological Association recommends preventing excessive straining to avoid pudendal neuropathy, which can be achieved by treating constipation aggressively before patients develop chronic straining patterns 4

Biofeedback therapy is the treatment of choice for patients with pelvic floor dysfunction from chronic straining, as it retrains proper pelvic floor coordination, with a success rate of more than 70% of patients with defecatory disorders, according to the American Gastroenterological Association 3
The European Society of Gastrointestinal Motility suggests that proper positioning during defecation, such as using a footstool to assist gravity, and avoiding prolonged straining, can help prevent further nerve injury 5
The American Gastroenterological Association advises against assuming all chronic constipation patients need more laxatives, and instead recommends biofeedback for those with pelvic floor dysfunction from years of straining 3

The American Gastroenterological Association recommends against withholding stimulant laxatives due to outdated fears about nerve damage, as they are safe for chronic use and prevent the straining that actually causes nerve injury 2
The European Society of Gastrointestinal Motility suggests recognizing that "tension" lasting years likely represents either pudendal neuropathy or learned pelvic floor dyssynergia, both of which require specialized assessment with anorectal testing 6